Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT05989945
Active, not recruiting Observational

HIDRAdenitis Suppurativa and HEART Disease

NCT05989945 · tracked via the Priya Life Science Denmark tracker
Sponsor
Herlev and Gentofte Hospital
Phase
Observational
Started
2023-08-01
Last updated
2025-08-01

Condition(s) studied

HidradenitisHidradenitis SuppurativaHidradenitis Suppurativa, FamilialLeft Ventricular DysfunctionMyocardial InfarctionMyocardial IschemiaHeart FailureStrokeHeart DiseasesHeart Failure, SystolicHeart Failure, Diastolic

Study summary

In a prospective observational cohort study (n = 250) the investigators aim to assess the correlation between cardiac biomarkers, advanced echocardiography and HS severity and determine whether these are prognostic markers of heart disease in patients suffering from hidradenitis suppurativa (HS).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of HS Exclusion Criteria: * Patients unable to cooperate to the study and/or study examinations * Patients unable to understand and sign informed consent

Primary outcome measure(s)

  • Cardiovascular mortality — 2, 5 and 10 year follow-up
  • Myocardial infarction — 2, 5 and 10 year follow-up
  • Coronary revascularization (percutaneous coronary intervention/coronary artery bypass graft) — 2, 5 and 10 year follow-up
  • Heart failure — 2, 5 and 10 year follow-up

Trial sites (1)

FacilityCityRegionStatus
Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen Hellerup Copenhagen

More Herlev and Gentofte Hospital trials in Denmark

The COLchicine and Atrial FIBrillation Trial Recruiting
Migration and Functional Outcome of DELTA Xtend Reverse Shoulder Lateralized Glenosphere Line Extension System Recruiting
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record Recruiting
HALO-TRIAL: High, Medium And LOw Intensity Psychotherapy for Binge Eating Disorder Recruiting
Implementation of Nutritional Efforts on Discharged Older Patients Recruiting

Other trials for the same condition

Quality of Life After Transcatheter Aortic Valve Implantation Active, not recruiting
The Nordic Aortic Valve Intervention Trial 4 (NOTION-4) Active, not recruiting
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05989945 on ClinicalTrials.gov ↗ ← All trials in Denmark